EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
1,980,641
Share change
+180,473
Total reported value
$5,072,000
Price per share
$2.56
Number of holders
20
Value change
+$447,296
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q2 2017

As of 30 Jun 2017, EVOKE PHARMA INC - COM (EVOK) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,980,641 shares. The largest 10 holders included VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., STATE TREASURER STATE OF MICHIGAN, Knoll Capital Management, LP, PRECEPT MANAGEMENT LLC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Commonwealth Equity Services, Inc, NORTHERN TRUST CORP, and Bank of New York Mellon Corp. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.